The scientific objectives of MEVIR are as follows:                            

• Establishment and expansion of a multidisciplinary cross-border network of experts for the surveillance and prevention of STVIs in the region.
  
• Expansion and operation of molecular diagnostic infrastructure, enabling large scale STVI population screening in the region. Specifically:
  

- Upgrading existing high-end equipment

- Establishing technical experience and transfer of know-how from the Greek to the Bulgarian partners

• Launch of a new molecular diagnostic facility in Kardzhali, Bulgaria, supported by personnel recruitment and training in STVI population screening programs:

• Evaluation of molecular diagnostic methods for STVIs, in terms of workflow management and quality control.

• Establishment of a biobank of clinical specimens and relevant database with STVI-related demographic, socio-economical, clinical and molecular data for the purposes of genetic analysis and validation. Specifically:
  

- Determination of suitable strategies and protocols for sample collection, storage and transport

- Assessment of the effectiveness of STVI diagnosis in reducing the risk for related neoplasias and foetal abortion  

• Epidemiological mapping of local prevalence of STVIs and identification of potential high-risk subgroups in the two countries.

• Dissemination of the project outcomes to target groups, involving:
  

- Health education of young people and their parents

- Dissemination of project activities to the media and decision-making bodies

- Endorsement of HPV vaccination as a key element to effective prevention and control of cervical cancer

- Dissemination to the broader scientific community through international conferences